Matches 51 - 63 out of 63 < 1 2


Match Document Document Title Score
EP2709610A1 HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION   454
6359016 Topical suspension formulations containing ciprofloxacin and dexamethasone  
Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically...
434
US20030055102 Olopatadine formulations for topical administration  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of...
430
8399508 Olopatadine formulations for topical nasal administration  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
417
6284804 Topical suspension formulations containing ciprofloxacin and dexamethasone  
Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically...
403
EP2977042A1 OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6 % (w/v) of olopatadine.
389
8791154 High concentration olopatadine ophthalmic composition  
The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high...
365
7001615 Sustained release ophthalmic, otic and nasal suspension  
Sustained release suspension formulations for ophthalmic, otic and nasal administration are disclosed. The formulations comprise a basic active, a cation exchange resin, and a combination of a...
360
7977376 Olopatadine formulations for topical nasal administration  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
323
EP2114367B1 OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION   314
6995186 Olopatadine formulations for topical administration  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of...
310
7402609 Olopatadine formulations for topical administration  
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of...
306
9533053 High concentration olopatadine ophthalmic composition  
The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high...
289


Search
Matches 51 - 63 out of 63 < 1 2
« search again